Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma.
Choueiri TK, Tomczak P, Park SH, Venugopal B, Ferguson T, Symeonides SN, Hajek J, Chang YH, Lee JL, Sarwar N, Haas NB, Gurney H, Sawrycki P, Mahave M, Gross-Goupil M, Zhang T, Burke JM, Doshi G, Melichar B, Kopyltsov E, Alva A, Oudard S, Topart D, Hammers H, Kitamura H, McDermott DF, Silva A, Winquist E, Cornell J, Elfiky A, Burgents JE, Perini RF, Powles T; KEYNOTE-564 Investigators. Choueiri TK, et al. N Engl J Med. 2024 Apr 18;390(15):1359-1371. doi: 10.1056/NEJMoa2312695. N Engl J Med. 2024. PMID: 38631003 Clinical Trial.
Efficacy and safety of axitinib for metastatic renal cell carcinoma: Real-world data on patients with renal impairment.
Minami K, Osawa T, Kojima T, Hara T, Eto M, Takeuchi A, Nakai Y, Ueda K, Ozawa M, Uemura M, Ohba K, Tamura K, Shindo T, Nakagomi H, Takahashi A, Anai S, Yokomizo A, Morizane S, Kimura T, Shimazui T, Miyauchi Y, Mitsuzuka K, Hara H, Yoshimura K, Shiina H, Ito YM, Murai S, Nishiyama H, Shinohara N, Kitamura H; Japanese Urological Oncology Group. Minami K, et al. Among authors: mitsuzuka k. Urol Oncol. 2023 Nov;41(11):458.e9-458.e19. doi: 10.1016/j.urolonc.2023.08.008. Epub 2023 Oct 3. Urol Oncol. 2023. PMID: 37798145
Improving compliance with guidelines may lead to favorable clinical outcomes for patients with non-muscle-invasive bladder cancer: A retrospective multicenter study.
Sato T, Sano T, Kawamura S, Ikeda Y, Orikasa K, Tanaka T, Kyan A, Ota S, Tokuyama S, Saito H, Mitsuzuka K, Yamashita S, Arai Y, Kobayashi T, Ito A. Sato T, et al. Among authors: mitsuzuka k. Int J Urol. 2023 Dec;30(12):1155-1163. doi: 10.1111/iju.15294. Epub 2023 Sep 4. Int J Urol. 2023. PMID: 37665144
Increasing age predicts adverse pathology including intraductal carcinoma of the prostate and cribriform patterns in deferred radical prostatectomy after upfront active surveillance for Gleason grade group 1 prostate cancer: analysis of prospective observational study cohort.
Tohi Y, Ishikawa R, Kato T, Miyakawa J, Matsumoto R, Mori K, Mitsuzuka K, Inokuchi J, Matsumura M, Shiga K, Naito H, Kohjimoto Y, Kawamura N, Inoue M, Akamatsu S, Terada N, Miyazawa Y, Narita S, Haba R, Sugimoto M. Tohi Y, et al. Among authors: mitsuzuka k. Jpn J Clin Oncol. 2023 Oct 4;53(10):984-990. doi: 10.1093/jjco/hyad088. Jpn J Clin Oncol. 2023. PMID: 37496400
Real-world outcomes of patients with renal cell carcinoma, surgically treated at regional hospitals, based on a prospective long-term survey of the pre-robotic era.
Kawasaki Y, Saito H, Ioritani N, Tochigi T, Numata I, Numahata K, Soma F, Kyan A, Ishidoya S, Ota S, Namima T, Orikasa K, Yamashita S, Mitsuzuka K, Arai Y, Ito A. Kawasaki Y, et al. Among authors: mitsuzuka k. Int Urol Nephrol. 2023 Apr;55(4):875-882. doi: 10.1007/s11255-023-03477-5. Epub 2023 Feb 13. Int Urol Nephrol. 2023. PMID: 36781679 Free PMC article.
Deliberation on Deferred Cytoreductive Nephrectomy and Postoperative Treatment for Advanced Renal Cell Carcinoma: A Case Report.
Nakagawa T, Kawasaki Y, Sato S, Katayama H, Satake Y, Shimada S, Sato T, Kawamorita N, Yamashita S, Mitsuzuka K, Kohyama A, Ishida M, Ohtsuka H, Unno M, Ito A. Nakagawa T, et al. Among authors: mitsuzuka k. Case Rep Oncol. 2022 Nov 8;15(3):1014-1020. doi: 10.1159/000527089. eCollection 2022 Sep-Dec. Case Rep Oncol. 2022. PMID: 36636673 Free PMC article.
159 results